Endometrioma
41
10
10
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.4%
1 terminated out of 41 trials
93.8%
+7.2% vs benchmark
7%
3 trials in Phase 3/4
0%
0 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (41)
Laparoscopic Sclerotherapy for the Management of Ovarian Endometriomas
Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis
Ablative Technique For Ovarian Preservation In Endometrioma
PET/MRI for Evaluation of Endometriosis
Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)
The Therapy of Large Endometrioma
Endometrioma Sclerotherapy and Ovarian Preservation
Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol
Estetrol/Drospirenone to Reduce the Average Size of Endometriomas
Conservative Endometrioma Surgery
Ethanol Sclerotherapy Prior to ART
Hemostatic Measures During Laparoscopic Cystectomy for Endometrioma
Laparoscopic Therapy of Endometrioma: Sclerotherapy vs Cystectomy in Patients With Unfinished Reproductive Plans
Two-session Catheter-directed Sclerotherapy Using Ethanol for Endometrioma
Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization
Optimum Menstrual Cycle Time for Endometrioma Excision
Comparison of Thyroid Volumes in Patients With and Without Endometrioma
Effect of Management of the Endometrioma on Ovarian Reserve
Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial
Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo